LATEST TWEETS - CURATED BY HASH FINANCE
$BMEA 1D
-The more I look at this daily, the more I like it https://t.co/b9hpyz5H6F
$BMEA:
New Insider Filing on Biomea Fusion, Inc.'s
Director
ELIZABETH FAUST:
https://t.co/LuEuUMk0GC
$BMEA:
New Insider Filing on Biomea Fusion, Inc.'s
Director
SUMITA RAY:
https://t.co/eAVg1KGpMZ
$BMEA:
New Insider Filing on Biomea Fusion, Inc.'s
Director
ELIZABETH FAUST:
https://t.co/TglY0x1h76
$BMEA:
New Insider Filing on Biomea Fusion, Inc.'s
Director
ERIC AGUIAR:
https://t.co/TsdYw8YbhE
$BMEA look at the volume today. Insane.
https://t.co/q3hBXcc9PZ https://t.co/0ZHowhCRm8 https://t.co/u2WjTdd7Lp
$BMEA | Alert #1 | Riskiest Play | RVOL: 2.9 | Price 11.7.
Up 3.72% since 1st alert.
This alert is delayed by 15 mi… https://t.co/mqaJsNuN3N
Biopharma Co. Doses First MM Patient in Ph. 1 Leukemia Trial: https://t.co/JnCzDCvFoN
$BMEA #biopharma #leukemia… https://t.co/gZ5N3tYtU2
Biopharma Co. Doses First MM Patient in Ph. 1 Leukemia Trial: https://t.co/ID1GebaC5O
$BMEA #biopharma #leukemia… https://t.co/nVIkjHW0CG
$BMEA's 10-day Moving Average crossed above its 50-day Moving Average on May 19, 2022. View odds for this and other… https://t.co/Eq1xnVDgZl
$BMEA's 10-day Moving Average moved above its 50-day Moving Average on May 19, 2022. View odds for this and other i… https://t.co/v4gBn7TLca
@MarketRebels $BMEA is on 🔥🔥🔥. This will be a multi billion dollar company in the future. I'm buying as much as I can.
$BMEA 8-K Biomea Fusion (23 Jun, 4:01pm)
📰 Submission of Matters to a Vote of Security Holders… https://t.co/1adiXNerEH
$BMEA Buy signal in place. Support and Resistance from $20.24 to $2.84. Free trial at https://t.co/5vcNxlk6G0 #BMEA https://t.co/vzJ14Gf8tP
#BiomeaFusion Announces First Patient Dosed in Multiple #Myeloma Cohort of #COVALENT101 Trial $BMEA https://t.co/7euE8Fl1rk
NEWS: $BMEA Biomea Fusion Announces First Patient Dosed in Multiple Myeloma Cohort of COVALENT-101 Trial… https://t.co/KyxEIrJVZd
Biomea Fusion today announced that the first patient has been dosed in the #MultipleMyeloma cohort of COVALENT-101… https://t.co/AE4IcPdPI2
$BMEA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/ULIZGsk3lE
Biomea Fusion Announces First Patient Dosed in Multiple Myeloma Cohort of COVALENT-101 Trial. @biomeafusion
$BMEA
https://t.co/QfM79FcCTP
FDA BIOTECH TRIAL = $BMEA = like if you BULLISH !
#StockMarketindia #NFTCommunity #cryptocurrency
https://t.co/KOxm2SqmhG
